ÂÜÀòÂÒÂ×

Tressa Randall brings over 25 years of regulatory and quality experience in the global biopharmaceutical industry. Prior to joining Faraday in September 2019, Ms. Randall served as Vice President, Regulatory Affairs and Quality at Nohla Therapeutics, Inc. from 2017 to 2019. She also served as Senior Director at Zymeworks, Inc. in 2017 as well as Vice President of Regulatory Affairs at VentiRx Pharmaceuticals, Inc. from 2007 to 2016. She has also worked as a principal regulatory scientist at ICOS Corporation and manager of Regulatory Affairs at NeoRX Corporation. She received a Bachelor of Science from Washington State University.